Bangkok Lab And Cosmetic PCL (BKK:BLC)

Market Cap	2.32B -13.5%
Revenue (ttm)	1.68B +6.3%
Net Income	173.02M +1.0%
EPS	0.29
Shares Out	600.00M
PE Ratio	13.31
Forward PE	n/a
Dividend	0.25 (6.48%)
Ex-Dividend Date	Apr 9, 2026

Volume	765,500
Average Volume	506,076
Open	3.880
Previous Close	3.840
Day's Range	3.860 - 3.940
52-Week Range	3.380 - 5.200
Beta	0.54
RSI	42.66
Earnings Date	Feb 24, 2026

About BKK:BLC

Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and ret...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1992
• Employees: 1,006
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BLC

Financial Performance

In 2025, BKK:BLC's revenue was 1.68 billion, an increase of 6.31% compared to the previous year's 1.58 billion. Earnings were 173.02 million, an increase of 0.97%.